Prelude Therapeutics OverviewPrelude Therapeutics Operating Income
Operating Income for PRLD.
Quarterly Operating Income
$-14177000.00
↓ 59.03% YoY
As of Mar 31, 2026
Annual Operating Income (TTM)
$-84137000.00
↓ 39.89% YoY
Trailing 12 months ending Mar 31, 2026